-
News
OKYO Pharma Announces Custom Clearance of GMP Packaged OK-101 Drug to be Used in Phase 2 Clinical Trial for Treating Dry Eye Disease
OKYO Pharma Limited (LSE: OKYO; NASDAQ: OKYO), an ophthalmology-focused bio-pharmaceutical company which is developing OK-101 to treat dry eye disease…
Read More » -
Regence and Equip partner to offer virtual eating disorder treatment for people aged 6 to 24
[ad_1] (NewMediaWire) – February 27, 2023 – Portland, OR – Eating disorders rose sharply during the COVID-19 pandemic – particularly…
Read More » -
Bubblr Inc. Announces Strategic New Patent Filed With the U.S. Patent and Trademark Office
[ad_1] New York, NY – (NewMediaWire) – February 27, 2023 – Bubblr Inc. (OTC PINK: BBLR), an ethical technology company…
Read More » -
News
OKYO Pharma Announces Appointment of Dr. Jay S. Pepose to its Scientific Advisory Board
OKYO Pharma Limited (LSE: OKYO, NASDAQ: OKYO), an ophthalmology-focused bio-pharmaceutical company developing OK-101 to treat dry eye disease (DED) to…
Read More » -
News
Lunchtime Results Launches Lunchtime Results App, Offers Instant Access to the UK 49s Lunchtime Results
[ad_1] Cape Town, South Africa – (NewMediaWire) – February 27, 2023 – (King Newswire) – In the latest development, Lunchtime Results…
Read More »